NASDAQ · BIB
ProShares Ultra Nasdaq Biotechnology
$120.53+$0.00 (0.0%)
ProShares Ultra Nasdaq Biotechnology’s quoted price sits in the upper half of its reported 52-week range, 4.64% below the high.
Loading market information…
AMEX · URE · USD
Stock price, dividends
Quote as of Oct 30, 2026, 07:59 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
ProShares Ultra Real Estate’s quoted price sits in the lower half of its reported 52-week range, 13.75% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
ProShares Ultra Real Estate’s forward annual dividend is $0.97 per share, paid quarterly. The forward yield is 1.49% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
The fund invests in financial instruments that the advisors believe, in combination, should produce daily returns consistent with the Daily Target. The index is designed to measure the performance of real estate companies included in the S&P 500 Index. Under normal circumstances, the fund will obtain leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 03:13 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$120.53+$0.00 (0.0%)
ProShares Ultra Nasdaq Biotechnology’s quoted price sits in the upper half of its reported 52-week range, 4.64% below the high.
$38.63-$1.10 (-2.77%)
Praxis Impact Large Cap Growth ETF’s quoted price sits in the upper half of its reported 52-week range, 8.04% below the high.
$82.77-$1.65 (-1.95%)
ProShares - S&P 500 Ex-Financials ETF’s quoted price sits in the upper half of its reported 52-week range, 4.17% below the high.
$28.12-$0.03 (-0.11%)
Cohen & Steers Real Estate Active ETF’s quoted price sits in the upper half of its reported 52-week range, 6.48% below the high.
$27.25-$0.50 (-1.79%)
Suncoast Select Growth ETF’s quoted price sits in the upper half of its reported 52-week range, 4.62% below the high.
$39.89-$0.51 (-1.25%)
Innovator Buffer Step-Up Strategy ETF’s quoted price sits in the upper half of its reported 52-week range, 2.07% below the high.
$100.70-$0.22 (-0.22%)
Invesco Active U.S. Real Estate ETF’s quoted price sits in the upper half of its reported 52-week range, 7.43% below the high.
$29.12-$0.43 (-1.46%)
MRP SynthEquity ETF’s quoted price sits in the lower half of its reported 52-week range, 16.68% below the high.
